Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Development and application of an ultra-sensitive ctDNA mutation profiling assay in monitoring therapy response and drug resistance.
Authors
Tom Zhang
Predicine, Inc., Hayward, CA
Tom Zhang , Harshabad Singh , Lu Tan , Xiaohong Wang , Zhixin Zhao , Kemin Zhou , Shujun Luo , Shidong Jia , Pan Du
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Diagnostics
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 264)
DOI
10.1200/JCO.2024.42.3_suppl.264
Abstract #
264
Poster Bd #
C2
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Morphologic and molecular analysis of early-onset gastroesophageal adenocarcinomas.
First Author: Namrata Setia
Poster
2019 ASCO Annual Meeting
A landscape of circulating tumor DNA in esophageal adenocarcinoma and squamous cell carcinoma.
First Author: Kabir Mody
Poster
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of appendiceal adenocarcinoma.
First Author: Kanwal Pratap Singh Raghav
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss